Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 15/20 | 0.90 |
| ▸ | RAB9A | P51151 | 15/20 | 0.90 |
| ▸ | SMN1; SMN2 | Q16637 | 9/20 | 0.90 |
| ▸ | HPGD | P15428 | 7/20 | 0.79 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.79 |
| ▸ | GLA | P06280 | 1/20 | 0.79 |
| ▸ | MAPT | P10636 | 1/20 | 0.79 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.79 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.75 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.75 |
| ▸ | RELA | Q04206 | 2/20 | 0.75 |
| ▸ | POLB | P06746 | 1/20 | 0.75 |
| ▸ | MEN1 | O00255 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.75 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.71 |
| ▸ | GAA | P10253 | 1/20 | 0.68 |
| ▸ | CA1 | P00915 | 2/20 | 0.66 |
| ▸ | CA2 | P00918 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22858502 | 1.00 | NPC1 (0.90) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL74999 | 1.00 | NPC1 (0.90) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL522555 | 1.00 | NPC1 (0.90) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL1105099 | 0.97 | NPC1 (0.85) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL4343181 | 0.97 | NPC1 (0.94) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL46426 | 0.95 | NPC1 (1.00) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL12306750 | 0.91 | NPC1 (0.74) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL12765574 | 0.91 | RAB9A (0.76) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL12111793 | 0.91 | NPC1 (0.74) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 | |
| SCHEMBL19391492 | 0.91 | NPC1 (0.74) | NPC1RAB9ASMN1; SMN2HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 975 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12581795-B2 | Display device and method for manufacturing same | SHARP KABUSHIKI KAISHA (JP) | 2026-03-17 | — | — | US | claimed |
| US-12495665-B2 | Display device having carrier blocking section between pixels | SHARP KABUSHIKI KAISHA (JP) | 2025-12-09 | — | — | US | claimed |
| US-12129414-B2 | Defect-resistant plastic scintillation radiation detector compositions and fabrication methods | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2024-10-29 | — | — | US | claimed |
| CN-118265372-A | Display substrate, manufacturing method thereof and display device | 京东方科技集团股份有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-112018267-B | Display panel, display device and preparation method | 京东方科技集团股份有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-110655922-B | Using In 3+ Wavelength tuning of ZnSe quantum dots with salts as dopants | 昭荣化学工业株式会社 | 2024-02-27 | — | — | CN | claimed |
| US-11914085-B2 | Plastic scintillator based on an organic polyaddition product | TARGET SYSTEMELEKTRONIK GMBH & CO. KG (DE) | 2024-02-27 | — | — | US | claimed |
| US-20230389392-A1 | DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME | SHARP KABUSHIKI KAISHA (JP) | 2023-11-30 | — | — | US | claimed |
| CN-116940197-A | Light emitting diode and preparation method thereof | TCL科技集团股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| US-20230309334-A1 | DISPLAY DEVICE AND METHOD FOR MANUFACTURING SAME | SHARP KABUSHIKI KAISHA (JP) | 2023-09-28 | — | — | US | claimed |
| EP-0831676-A2 | Organic electroluminescent element with exciplex | Philips Patentverwaltung GmbH (DE) | 1998-03-25 | — | — | EP | claimed |
| US-5529869-A | IMPROVED ELECTRICAL CHARGE ACCEPTANCE AND CHARGE RETENTION ABILITY | HEWLETT-PACKARD COMPANY (US) | 1996-06-25 | — | — | US | claimed |
| EP-0697744-A1 | Organic electroluminescent device | Philips Patentverwaltung GmbH (DE) | 1996-02-21 | — | — | EP | claimed |
| US-5308544-A | A solution of naphthalene, a fluorescent compound and a radioactive beta emitter | BECKMAN INSTRUMENTS, INC. (US) | 1994-05-03 | — | — | US | claimed |
| WO-1991011735-A1 | SCINTILLATION MEDIUM AND METHOD | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-08-08 | — | — | WO | claimed |
| US-4997597-A | Solid-state radioluminescent compositions | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1991-03-05 | — | — | US | claimed |
| US-4758488-A | Stabilized polysilylenes and imaging members therewith | XEROX CORPORATION (US) | 1988-07-19 | — | — | US | claimed |
| US-4728796-A | Method for ionization of polymers | MEDICAL COLLEGE OF WISCONSIN (US) | 1988-03-01 | — | — | US | claimed |
| US-4594179-A | Activation, intramolecular rearrangement | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1986-06-10 | — | — | US | claimed |
| US-4292527-A | Radiation detection system | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1981-09-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12581795-B2 | Display device and method for manufacturing same | EPHA4, NECTIN4, L1CAM | NPC1 2199/4885RAB9A 1568/4885SMN1; SMN2 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.